Table 1.
Clinical and demographic data of the studied population
| Variable | T1DM | T2DM |
|---|---|---|
|
N |
82 |
304 |
|
Gender (female) n (%) |
43 (52%) |
204 (67%) |
|
Age (years) |
33.5 ± 15,8 |
60.7 ± 10.6 |
|
Diabetes duration (years) |
14.6 ± 11.7 |
14.8 ± 10.5 |
|
Ethnicity, n (%) |
|
|
|
Caucasian |
37 (45%) |
127 (42%) |
|
Non-caucasion |
45 (55%) |
177 (58%) |
|
Hypertension (yes) |
16 (19.5%) |
243 (79.9%) |
|
Dyslipidemia (yes) |
21 (25.6%) |
209 (68.8%) |
|
Previous thyroid disease n(%) |
|
|
|
Yes |
12 (15%) |
37 (12%) |
|
No |
61 (74%) |
184 (60%) |
|
Unknown |
9 (11%) |
83 (28%) |
|
BMI (kg/m2) |
24,4 ± 5,2 |
30,3 ± 5,1 |
|
sBP (mmHg) |
111 ± 16 |
131 ± 20 |
|
dBP (mmHg) |
79 ± 10 |
75 ± 11 |
|
FPG (mg/dL) |
141 ± 85,5 |
139 ± 74,9 |
|
2 h-PPG (mg/dL) |
216 ± 96,0 |
215 ± 81,5 |
|
HbA1c (%) |
12,3 ± 3,1 |
8,3 ± 1,8 |
|
TSH (μUI/mL) |
2,60 ± 1,80 |
2,53 ± 2,24 |
|
FT4 (μUI/mL) |
1,29 ± 0,17 |
1,31 ± 0,33 |
| Anti-TPO (yes) | 12 (14.6%) | 30 (9.9%) |
Data are presented as mean ± SD, n (%). sBP, systolic blood pressure; dBP, diastolic blood pressure; BMI, body mass index; FPG, fasting blood glucose; 2 h- PPG, 2 h postprandial glucose.